Drugs / dehydrobenzperidol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 3 | NCT03825198 Comparator | Aug 2019 → Dec 2023 | neuropathy, painful, peripheral nerve lesion | Dr M. B. Breebaart | Unknown | No outcome recorded |
| Phase 4 | NCT02078336 Comparator | Dec 2013 → Jul 2025 overdue | — | Universitaire Ziekenhuizen KU Leuven | Active not recruiting | No outcome recorded |
| — | NCT03036514 Comparator | Apr 2017 → Aug 2019 | neuropathy, painful | University Hospital, Antwerp | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dehydrobenzperidol | “postoperative morphine pomp, controlled by the patient. ( bolus 1 mg, lockout 8 minutes) the solution contains morphine 1 mg/ml + dehydrobenzperidol 0,05 mg/ml” NCT03825198 ↗2“This classic patient-controlled IV-pump contains 1mg/ml morphine and 50mcg/ml dehydrobenzperidol.” NCT03036514 ↗ |
| Route | Intramuscular | “0,000125 ml/cm2 Intramuscular use Single dose 45 minutes before dental treatment” NCT02078336 ↗ |